These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35815048)

  • 1. Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults.
    Zhang X; Cai Y; Hu X; Lu CY; Nie X; Shi L
    Front Psychiatry; 2022; 13():922648. PubMed ID: 35815048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis.
    Meeker AS; Herink MC; Haxby DG; Hartung DM
    Syst Rev; 2015 Mar; 4():21. PubMed ID: 25874839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
    Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
    JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.
    Imai H; Tajika A; Chen P; Pompoli A; Furukawa TA
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011170. PubMed ID: 27730622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vortioxetine: a New Treatment for Major Depressive Disorder.
    Connolly KR; Thase ME
    Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rosenblat JD; Kakar R; McIntyre RS
    Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta‑analysis of randomized controlled trials.
    Gao S; Xie X; Fan L; Zhang D
    Exp Ther Med; 2023 Nov; 26(5):515. PubMed ID: 37840562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants plus benzodiazepines for adults with major depression.
    Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial.
    Ostuzzi G; Gastaldon C; Tettamanti M; Cartabia M; Monti I; Aguglia A; Aguglia E; Bartoli F; Callegari C; Canozzi A; Carbone EA; Carrà G; Caruso R; Cavallotti S; Chiappini S; Colasante F; Compri B; D'Agostino A; De Fazio P; de Filippis R; Gari M; Ielmini M; Ingrosso G; Mammarella S; Martinotti G; Rodolico A; Roncone R; Sterzi E; Tarsitani L; Tiberto E; Todini L; Amaddeo F; D'Avanzo B; ; Barbato A; Barbui C
    EClinicalMedicine; 2024 Mar; 69():102491. PubMed ID: 38384338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis.
    He H; Wang W; Lyu J; Zheng J; Guo L; An X; Fan Y; Ma X
    J Psychiatr Res; 2018 Jan; 96():247-259. PubMed ID: 29127931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Vortioxetine for the Treatment of Major Depressive Disorder in the Real World: A Systematic Review and Meta-Analysis.
    Li Z; Liu S; Wu Q; Li J; Yang Q; Wang X; Peng P; Wang Q; Liu Y; Li M; Hao Y; Xu H; He L; Wang Y; Chen S; Liu T
    Int J Neuropsychopharmacol; 2023 Jun; 26(6):373-384. PubMed ID: 37105713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder.
    Brignone M; Diamand F; Painchault C; Takyar S
    Curr Med Res Opin; 2016; 32(2):351-66. PubMed ID: 26637048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.